• April 4, 2022

    The pandemic has caused problems in the forefront of predictability and access to medicines in the country. It was difficult to supply the basic (active) substances for pharmaceutical production, and a slight increase in the production of drugs.

     

    In this context, even before the first global lockdown, the team of Tchaikapharma has prepared a stategy for action in the unprecedented situation, by defining three main challenges.

     

    The full article is available here in Bulgarian.

  • April 1, 2022

    The first humanitarian aid from Pleven is already on its way to the twin city of Nikolayev, expected to arrive tomorrow at noon.

    The main donation consists of antiviral preparations, sleeping bags, external batteries for charging mobile phones, backpacks, lanterns – these were the requests of the local government in Nikolaev. The medicines were provided by Tchaikapharma High Quality Medicines through the Municipality of Pleven, the rest of the humanitarian aid was purchased from the financial donations of dozens of Pleven residents who supported the campaign.

  • March 15, 2022

    2021 was a very successful year for the manufacturing facilities of Tchaikapharma High Quality Medicines in Plovdiv and Varna. Numerous improvements related to the modernization of the manufactiring process were introduced at the company’s plant in Plovdiv:

    – a Production Permit was obtained for a new granulation room in the tablet manufacturing facility, doubling the capacity;

    – additional warehouses for shaped parts were built;

    – a capsule filling machine for solid capsules was purchased and installed;

    – a Manufacturing Permit was obtained to include a new manufacturing activity – production of non-sterile products – hard capsules;

    – a roller-compactor for dry granulation has been purchased and installed;

    – new serialization equipment with Temper Evident module was purchased and installed on packaging line 4;

    – a new high-performance liquid chromatography apparatus and a new stability monitoring chamber were purchased for the Quality Control Department.

    In 2021, the manufacturing of sterile antibiotics from the group of cephalosporins, has increased manifold at the plant of Tchaikapharma in Varna.

  • February 7, 2022

    The Company reports about growth in sales of antibiotics and respiratory drugs

     

    Tchaikapharma High Quality Medicines Inc. reports revenue growth and profit more than doubling by the end of 2021.  The company’s net profit at the end of the last quarter for 2021 amounted to BGN 1,667 million compared to BGN 604 thousand at the end of 2020, an increase of 176%.

     

    The strongest growth in 2021 was reported in sales of antibiotics and respiratory medicines, given the prevalence of COVID-19, to BGN 7,325 million compared to BGN 4,42 million in the previous year, or by 65,72% (BGN 2,9 million). There was also growth in sales of the company’s drugs for the nervous system, as well as for the digestive system and metabolism, oncology and musculoskeletal system and connective tissue.

     

    In the last year, Tchaikapharma’s shares rose by 9.5% and its market capitalisation reached BGN 1.1 billion.

     

    The full article is available here in Bulgarian.

  • January 10, 2022

    The newest medicinal product to receive a Marketing Authorization from the Bulgarian Drug Agency is:

     

    TromBay 100 mg tablets (with active ingredient cilostazol).

     

    Its actions are several and include dilating certain blood vessels and reducing the clotting activity (agglutination) of certain blood cells, called platelets, in blood vessels.

     

    The medicinal product is prescribed for “intermittent claudication” – a cramp-like pain in the legs when walking and is caused by insufficient blood supply to the lower limbs. TromBay can increase the distance you can walk without pain as it improves blood circulation in the legs. TromBay is only recommended for patients whose symptoms have not improved enough after making lifestyle changes (such as quitting smoking and increasing exercise) or after other appropriate treatments. It is important that patients continue with the changes they have made to improve their lifestyle while taking TromBay.

     

    The medicinal product is subject to prescription.

     

    ATC code: B01AC23